Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Current Assets (2020 - 2025)

Beauty Health (SKIN) has disclosed Current Assets for 6 consecutive years, with $309.5 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 35.13% to $309.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $309.5 million through Dec 2025, down 35.13% year-over-year, with the annual reading at $309.5 million for FY2025, 35.13% down from the prior year.
  • Current Assets for Q4 2025 was $309.5 million at Beauty Health, roughly flat from $308.4 million in the prior quarter.
  • The five-year high for Current Assets was $1.0 billion in Q4 2021, with the low at $3.3 million in Q1 2021.
  • Average Current Assets over 5 years is $602.2 million, with a median of $656.5 million recorded in 2023.
  • The sharpest move saw Current Assets soared 29236.2% in 2022, then tumbled 37.48% in 2025.
  • Over 5 years, Current Assets stood at $1.0 billion in 2021, then dropped by 21.74% to $783.3 million in 2022, then decreased by 10.85% to $698.3 million in 2023, then tumbled by 31.67% to $477.1 million in 2024, then crashed by 35.13% to $309.5 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $309.5 million, $308.4 million, and $306.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.